β-Nicotinamide mononucleotide

  • CAT Number: I000399
  • CAS Number: 1094-61-7
  • Molecular Formula: C11H15N2O8P
  • Molecular Weight: 334.2
  • Purity: ≥95%
Inquiry Now

β-Nicotinamide mononucleotide (β-NMN)(CAT: I000399) is a nucleotide derivative that plays a critical role in cellular metabolism and energy production. It is an intermediate molecule in the biosynthesis of nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in various cellular processes. β-NMN has gained significant attention in recent years due to its potential anti-aging properties. It is believed to enhance NAD+ levels, which decline with age, and activate sirtuins, a family of proteins associated with longevity. By increasing NAD+ levels, β-NMN may support cellular health, mitochondrial function, and overall tissue vitality. Additionally, it has been studied for its potential benefits in age-related conditions, metabolic disorders, and neurodegenerative diseases. While β-NMN shows promise, further research is needed to fully understand its mechanisms of action and therapeutic applications.

Catalog Number I000399
CAS Number 1094-61-7
Synonyms

β-NMN, β-Nicotinamide ribose monophosphate, NMN, Nicotinamide ribotide, Nicotinamide-1-ium-1-β-D-ribofuranoside 5′-phosphate

Molecular Formula

C11H15N2O8P

Purity 95%
Solubility H2O: ≥ 35 mg/mL
Storage -20°C
IUPAC Name [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
InChI InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/m1/s1
InChIKey DAYLJWODMCOQEW-TURQNECASA-N
SMILES O[C@H]1[C@@H](O)[C@H]([N+]2=CC(C(N)=O)=CC=C2)O[C@@H]1COP(O)([O-])=O
Reference

1: Ummarino S, Mozzon M, Zamporlini F, Amici A, Mazzola F, Orsomando G, Ruggieri S, Raffaelli N. Simultaneous quantitation of nicotinamide riboside, nicotinamide mononucleotide and nicotinamide adenine dinucleotide in milk by a novel enzyme-coupled assay. Food Chem. 2017 Apr 15;221:161-168. doi: 10.1016/j.foodchem.2016.10.032. Epub 2016 Oct 11. PubMed PMID: 27979136.<br />
2: Mart&iacute;nez-Mo&ntilde;ino AB, Zapata-P&eacute;rez R, Garc&iacute;a-Saura AG, Gil-Ortiz F, P&eacute;rez-Gilabert M, S&aacute;nchez-Ferrer &aacute;. Characterization and mutational analysis of a nicotinamide mononucleotide deamidase from Agrobacterium tumefaciens showing high thermal stability and catalytic efficiency. PLoS One. 2017 Apr 7;12(4):e0174759. doi: 10.1371/journal.pone.0174759. eCollection 2017. PubMed PMID: 28388636; PubMed Central PMCID: PMC5384747.<br />
3: Wei CC, Kong YY, Li GQ, Guan YF, Wang P, Miao CY. Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway. Sci Rep. 2017 Apr 6;7(1):717. doi: 10.1038/s41598-017-00851-z. PubMed PMID: 28386082; PubMed Central PMCID: PMC5429727.<br />
4: Yao Z, Yang W, Gao Z, Jia P. Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease. Neurosci Lett. 2017 Apr 24;647:133-140. doi: 10.1016/j.neulet.2017.03.027. Epub 2017 Mar 19. PubMed PMID: 28330719.<br />
5: Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, Yoshino J, Imai SI. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metab. 2016 Dec 13;24(6):795-806. doi: 10.1016/j.cmet.2016.09.013. Epub 2016 Oct 27. PubMed PMID: 28068222.

Request a Quote